SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

Cyclo Therapeutics, Inc. CYTH NASDAQ

NASDAQ Capital Marke • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Analyst Price Target

Cyclo Therapeutics, Inc. (CYTH) has 12 identified peers for comparison in the Healthcare sector. Peers include ACRX, AGRX, AMRX, AQST, ASRT, ATNX and others.

CYTH has a market capitalization of $23.59M, compared to an average peer market cap of $1.63B. CYTH is notably smaller than its average peer.

Peers & Similar Companies — CYTH

AcelRx Pharmaceuticals, Inc.

$0.86 +7.50% $14.58M

Agile Therapeutics, Inc.

$1.51 +3.42% $10.43M

Amneal Pharmaceuticals, Inc.

$13.12 +2.26% $4.13B

Aquestive Therapeutics, Inc.

$4.15 -0.95% $412.12M

Assertio Holdings, Inc.

$18.02 +0.03% $116.14M

$0.20 0.00% $2.33M

Eagle Pharmaceuticals, Inc.

$0.34 0.00% $4.43M

Guardion Health Sciences, Inc.

$3.25 +0.93% $4.17M

Ironwood Pharmaceuticals, Inc.

$4.04 +10.68% $658.75M

Intra-Cellular Therapies, Inc.

$131.87 0.00% $14.05B

Lifecore Biomedical, Inc.

$5.20 +5.26% $194.88M

Lucy Scientific Discovery Inc.

$0.51 -23.29% $906.91K

People Also View

Intra-Cellular Therapies, Inc.

Amneal Pharmaceuticals, Inc.

Phibro Animal Health Corporation

Ironwood Pharmaceuticals, Inc.

Aquestive Therapeutics, Inc.

Lifecore Biomedical, Inc.

Alpha Teknova, Inc.

Assertio Holdings, Inc.

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message